Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Preferred Shares (2022 - 2025)

Historic Preferred Shares for PAVmed (PAVM) over the last 4 years, with Q3 2025 value amounting to $20.5 million.

  • PAVmed's Preferred Shares changed N/A to $20.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.5 million, marking a year-over-year change of. This contributed to the annual value of $3.3 million for FY2024, which is 1079.18% up from last year.
  • According to the latest figures from Q3 2025, PAVmed's Preferred Shares is $20.5 million.
  • Over the past 5 years, PAVmed's Preferred Shares peaked at $22.9 million during Q1 2025, and registered a low of $2.5 million during Q1 2022.
  • For the 4-year period, PAVmed's Preferred Shares averaged around $6.8 million, with its median value being $3.0 million (2023).
  • As far as peak fluctuations go, PAVmed's Preferred Shares surged by 1079.18% in 2024, and later skyrocketed by 64496.91% in 2025.
  • PAVmed's Preferred Shares (Quarter) stood at $2.7 million in 2022, then increased by 11.06% to $3.0 million in 2023, then increased by 10.79% to $3.3 million in 2024, then skyrocketed by 517.97% to $20.5 million in 2025.
  • Its Preferred Shares stands at $20.5 million for Q3 2025, versus $21.1 million for Q2 2025 and $22.9 million for Q1 2025.